Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-02-15

FDA Approved: BIJUVA — Supplemental Application (Mayne Pharma)

View source ↗

Summary

The FDA approved a supplemental application for BIJUVA, a combination of estradiol and progesterone, submitted by Mayne Pharma. The approval pertains to changes…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BIJUVA (Estradiol and Progesterone)

Snippet

SUPPL AP for BIJUVA (ESTRADIOL AND PROGESTERONE)